Naturally Multi-Layer Amniotic Membranes: How Preserving Placental Structure Supports Healing

Table of Contents

• Introduction
• The Unique Structure of the Placenta
• What “Multi-Layer” Really Represents in Regenerative Healing
• How Multi-Layer Amniotic Membranes Enhance Healing
• Clinical Evidence: Faster, More Durable Outcomes
• Optimizing Protocol and Reimbursement
• Applications Beyond Wound Care
• Conclusion
• References

Chronic wounds affect more than 8.2 million Americans and represent a growing clinical and economic burden, contributing an estimated $33 billion annually to U.S. healthcare costs. Despite advances in dressings, compression therapy, and offloading strategies, many diabetic foot ulcers, venous leg ulcers, and pressure injuries fail to progress through normal phases of healing, placing patients at increased risk for infection, hospitalization, and amputation.

Placenta-derived amniotic membrane allografts have emerged as a biologically active option capable of modulating inflammation, supporting tissue regeneration, and restoring a physiologic wound environment. Among available placental biologics, naturally multi-layer amniotic membranes preserve the placenta’s native architecture, delivering structural integrity and biologic signaling that may improve both the speed and durability of wound healing.

The placenta is a temporary yet highly specialized organ that facilitates coexistence between two genetically distinct organisms while supporting rapid tissue growth and regeneration. Placental tissues are considered immune-privileged, meaning they lack vascular structures and express minimal major histocompatibility antigens, allowing clinical application with a low risk of rejection.

Within its layers lie the key components of biologic repair:

Hyaluronic acid and proteoglycans that maintain a moist, protective environment conducive to cellular migration

• Mesenchymal stem cells (MSCs) capable of differentiating into bone, cartilage, nerve, and skin.
• Growth factors and cytokines—including EGF, FGF, KGF, HGF, and TGF-β—that regulate inflammation and tissue remodeling.
• Hyaluronic acid and proteoglycans that maintain a moist, protective healing environment.

Together, these native components form a biologic scaffold that supports wound healing, surgical recovery, and tissue regeneration across multiple clinical applications [1].

Naturally multi-layer amniotic membranes retain multiple native placental layers rather than isolating a single surface. These layers typically include the amnion, an intermediate (spongy) layer, and the chorion, each contributing distinct structural and biologic functions that support tissue repair.

The amnion is the innermost placental layer and contains metabolically active epithelial and mesenchymal cells. It is rich in growth factors, cytokines, and antimicrobial peptides that suppress inflammation, reduce microbial burden, and promote epithelial migration. These properties support rapid surface regeneration while protecting the wound bed from external contamination [2,11].

The intermediate or spongy layer consists of a hydrated matrix rich in hyaluronic acid, proteoglycans, and collagen. This layer functions as a biologic cushion, absorbing mechanical stress while facilitating cellular migration. It also serves as a reservoir for regenerative signaling molecules such as HGF, bFGF, and PDGF, which contribute to angiogenesis and organized tissue remodeling while limiting fibrosis [12].

The chorion is the thicker, collagen-dense outer layer of the placenta, providing mechanical strength and tensile support. It contains angiogenic and immunomodulatory factors, including VEGF and PDGF, that promote neovascularization, recruit progenitor cells, and support long-term tissue remodeling. The chorion’s structural properties are particularly relevant in larger, deeper, or mechanically stressed wounds [13,14].

Together, these three preserved layers form a synergistic biologic matrix that delivers superior structural support, biochemical signaling, and protection—creating a regenerative environment proven to accelerate wound closure and improve long-term healing outcomes.

Human amniotic membrane (hAM) exhibits a unique combination of anti-inflammatory, antibacterial, immunomodulatory, angiogenic, and low-immunogenic properties [6,7]. When applied to chronic or surgical wounds, preserved multi-layer amniotic membranes function as both a biologic dressing and a regenerative scaffold.

When applied to a chronic or surgical wound, preserved hAM functions as both biologic dressing and regenerative template, providing:

• Inflammatory modulation, including suppression of pro-inflammatory cytokines and TGF-β signaling, reducing chronic inflammation and fibrosis
• Antimicrobial activity through natural peptides such as defensins and elafin
• Cell recruitment and signaling, facilitating endogenous repair processes
• Moisture regulation, supporting epithelial migration
• Pain reduction, secondary to decreased inflammatory signaling

Clinical studies and real-world data analyses demonstrate improved healing trajectories when amnion-chorion–based membranes are incorporated into advanced wound care protocols. Reported outcomes include accelerated wound closure, reduced recurrence rates, and sustained closure over long-term follow-up.

Timepoint	dHACM Weekly	dHACM Biweekly	Standard of Care
4 weeks	77 % healed	70%	0%
6 weeks	92 % healed	91%	8%
12 weeks	97 % healed	—	51%
12 months (remained closed)	94.4%	—	86%

Data summarized from Glat PM et al., Oltmann M DPM, Padula B PhD, and Li V (2019) [8–10].

In published analyses, weekly application of dehydrated human amnion/chorion membrane (dHACM) has been associated with significantly higher closure rates compared with standard care and biweekly application schedules, with over 94% of wounds remaining closed at 12-month follow-up [8–10].

Successful integration of multi-layer amniotic membranes into clinical practice depends on appropriate patient selection, wound bed preparation, and documentation. Common protocol elements include routine debridement, initiation of cellular and tissue-based products after failure of standard care, and reapplication at clinically appropriate intervals.

From a reimbursement standpoint, amniotic membrane allografts may be covered for specific indications when medical necessity criteria are met and documentation supports appropriate use. Clinicians must align biologic selection and application frequency with payer policies to ensure both compliance and sustainability.

Consistent technique and documentation drive success:

• Debride every 7–14 days to maintain a clean, vascular bed.
• Initiate CTPs within 30–45 days if standard therapy fails to progress.
• Reapply weekly until closure.
• Use NPWT or NPWT-instillation before grafting in heavily exudative or infected wounds.

Amniotic membranes are reimbursable under Medicare Q-codes for approved indications such as diabetic or venous ulcers > 1 cm² with adequate perfusion, provided documentation supports medical necessity [10]. Because Medicare assignment, Q-codes, ASP pricing, and MUE limits evolve on a quarterly basis, clinicians should reference current Medicare-approved amniotic membrane allografts when selecting specific products for use in advanced wound care programs.

Beyond chronic ulcers, placental-derived amniotic membranes have demonstrated utility across multiple specialties. Clinical applications include ophthalmology for ocular surface reconstruction, orthopedics for tendon and ligament support, plastic and reconstructive surgery to minimize scarring, and surgical settings where modulation of inflammation and tissue protection are critical.

• Ophthalmology – restoring corneal clarity and ocular surface integrity.
• Orthopedics – supporting tendon, ligament, and nerve healing.
• Plastic & reconstructive surgery – minimizing scarring and improving graft take.
• Spine and dental surgery – reducing fibrosis and protecting delicate tissues.

Each application leverages the same biologic strengths: immune privilege, anti-inflammatory signaling, and regenerative support.

Naturally multi-layer amniotic membranes preserve the placenta’s native architecture, delivering structural support and biologic signaling that contribute to tissue regeneration across a broad range of clinical applications. Their layered composition provides distinct advantages in wound healing, surgical recovery, and regenerative medicine.

For clinicians seeking to master the complexity of placental biologics, a deep understanding of tissue structure, mechanism of action, and evidence-based application is essential. When combined with coverage-aligned product selection, multi-layer amniotic membranes represent a powerful tool within advanced wound care programs. Coverage-aligned selection and documentation workflows are critical when integrating placental biologics into practice, particularly in Medicare-regulated environments.

Li V. Placental-Based Allografts: From Womb to Wound. HMP Education, 2019.

American Optometric Association. The Wonderful Healing Properties of Amniotic Membranes. [Accessed Oct 2025]. https://www.aoa.org/news/clinical-eye-care/health-and-wellness/the-wonderful-healing-properties-of-amniotic-membranes

University Orthopedic Care. Biological Scaffolds from Placental Membranes. June 2025. https://universityorthocare.com/biological-scaffolds-from-placental-membranes

National Institutes of Health (PMC). Human Amniotic Membrane Transplantation: Different Modalities of Application. https://pmc.ncbi.nlm.nih.gov/articles/PMC4094946/

National Institutes of Health (PMC). Amniotic Membrane Can Be a Valid Source for Wound Healing. https://pmc.ncbi.nlm.nih.gov/articles/PMC4930235/

Gholipourmalekabadi M., Sameni M., Radenkovic D., Mozafari M., Mossahebi-Mohammadi M., Seifalian A. Decellularized Human Amniotic Membrane: How Viable Is It as a Delivery System for Adipose-Derived Stromal Cells? Cell Prolif. 2016; 49(1): 115–121. doi:10.1111/cpr.12240.

Leal-Marin S., Kern T., Hofmann N., Pogozhykh O., Framme C., Börgel M., Figueiredo C., Glasmacher B., Gryshkov O. Human Amniotic Membrane: A Review on Tissue Engineering, Application, and Storage. J. Biomed. Mater. Res. B Appl. Biomater. 2021; 109(8): 1198–1215. doi:10.1002/jbm.b.34782.

Glat P.M., MD. Optimizing Cost-Effectiveness and Clinical Outcomes of dHACM in Lower Extremity Ulcer Treatment.

Oltmann M., DPM. Advanced Treatment with Skin Substitutes for LEDU.

Padula B., PhD. Clinical and Economic Impact of CTPs in the Medicare Database.

University Orthopedic Care. Biological Scaffolds from Placental Membranes. [Amnion section]. https://universityorthocare.com/biological-scaffolds-from-placental-membranes

National Institutes of Health (PMC). Human Amniotic Membrane Promotes Proliferation of Fibroblasts In Vitro. https://pmc.ncbi.nlm.nih.gov/articles/PMC10649069/

MDPI. The Role of the Chorion in Regenerative Wound Healing. Int. J. Mol. Sci. 2024; 25(22):11893. https://www.mdpi.com/1422-0067/25/22/11893

American Optometric Association. The Wonderful Healing Properties of Amniotic Membranes. [Chorion summary].